Comparison of Saliva Biomarkers in Two Different Geographical Regions of Turkey
NCT06809439 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77
Last updated 2025-02-05
Summary
Periodontitis is a multifactorial, chronic inflammatory disease caused by many factors such as pathogenic microorganisms, host response, environmental and systemic factors. Immune mechanisms triggered by host-bacteria interaction can initiate tissue destruction by leading to the release of large amounts of inflammatory mediators such as IL-1β. It is thought that IL-10 has a regulatory role by limiting the initiation and progression of the acute inflammatory response with its anti-inflammatory effect. The high detection of RANKL and RANKL/OPG ratios in periodontitis indicates that these markers play a role in bone destruction. Elucidating the connections between the immune system and bone-related cytokines will contribute significantly to the resolution of these complex mechanisms underlying periodontal diseases. Risk factors for periodontal diseases include gender, age, smoking and some hereditary factors. Cortisol is an important marker of psychological stress. It is emphasized that stress and depression reduce immune system function and cause chronic inflammation. Thus, it indirectly provokes periodontal tissue destruction.
Conditions
- Saliva
- Cortisol
- Smoking, Tobacco
- Periodontal Bone Loss
- Periodontal Disease
- Periodontal Therapy
Interventions
- PROCEDURE
-
Non-Surgical Intervention
Oral hygiene instructions including tooth brushing, flossing, and interdental brushing were given to all patient groups before non-surgical periodontal treatment. In both periodontitis groups, scaling, and root surface smoothing were performed using ultrasonic instruments (Woodpecker Medicals Ins. Co., USA) and Gracey Curettes (Hu-Friedy, Chicago, IL, USA) under local anesthesia once a week for 4 weeks.
- DIAGNOSTIC_TEST
-
Saliva Collection (Baseline)
Unstimulated saliva samples were collected from all participants between 9:00 and 11:00 am. Clinical periodontal measurements were performed after saliva collection to prevent contamination (bleeding, etc.). Participants refrained from brushing their teeth the morning before sampling and from eating, drinking, or smoking for at least 2 hours before sampling. Patients were asked to rinse their mouths with distilled water 5 minutes before saliva collection. A saliva sample was then collected by spitting directly into a sterile tube. Sample collection was continued for 5 minutes.
- OTHER
-
Probing
Clinical and radiographic evaluations were performed by trained and calibrated examiners at Ankara University (SY) and Ataturk University (OT). Clinical parameters of probing depth (PPD), clinical attachment level CAL, plaque index PI, and bleeding on probing (BOP) were recorded from six tooth regions (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, middle lingual, and disto-lingual) using periodontal probe. Bone loss was assessed using panoramic radiographs, confirming the diagnosis of periodontitis.
- DIAGNOSTIC_TEST
-
Saliva Collection (After treatment)
Unstimulated saliva samples were collected from all participants between 9:00 and 11:00 am. Clinical periodontal measurements were performed after saliva collection to prevent contamination (bleeding, etc.). Participants refrained from brushing their teeth the morning before sampling and from eating, drinking, or smoking for at least 2 hours before sampling. Patients were asked to rinse their mouths with distilled water 5 minutes before saliva collection. A saliva sample was then collected by spitting directly into a sterile tube. Sample collection was continued for 5 minutes.
Sponsors & Collaborators
-
Ataturk University
collaborator OTHER -
Ankara University
collaborator OTHER -
Karabuk University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-01-02
- Primary Completion
- 2023-05-08
- Completion
- 2023-07-03
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Nonsurgical Periodontal Treatment Combined With Anti-TNF-α in Patients With Rheumatoid Arthritis and Periodontitis
NCT06818045 ·Status: COMPLETED ·Phase: NA
-
GCF Levels of IL-1β and IL-6 in Gingivitis and Stage III-Grade C Periodontitis
NCT04689438 ·Status: COMPLETED
-
Evaluation of Salivary Biomarker Levels of Individuals With Different Periodontal Diseases
NCT05774925 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Salivary Galectin-8, Galectin-9 and RANKL Levels of Individuals With Different Periodontal Diseases
NCT06404476 ·Status: RECRUITING ·Phase: NA
-
Salivary Proteome in Response to Non-surgical Periodontal Treatment
NCT05952895 ·Status: COMPLETED
-
IL-10, IL-12 and IL-18 Levels in the Gingival Crevicular Fluid of Patients With Periodontitis and Healthy Controls
NCT05307068 ·Status: COMPLETED
-
Gingival Crevicular Fluid, Salivary, and Serum Biomarkers Levels in Periodontal Treatment
NCT05395455 ·Status: COMPLETED ·Phase: NA
-
Effect of Nonsurgical Periodontal Treatment on Apelin and Oxidative Stress Levels
NCT06850987 ·Status: COMPLETED
-
Evaluation of Salivary Gal-7, Gal-10 and MMP-9 Levels of Individuals With Different Periodontal Diseases
NCT06186908 ·Status: RECRUITING ·Phase: NA
-
The Importance of Prostaglandin and Nitric Oxide Synthesis in Apical Periodontitis
NCT06023901 ·Status: COMPLETED ·Phase: NA
-
Effect of Non-Surgical Periodontal Treatment on Gingival Crevicular Fluid and Serum Biomarker Levels
NCT06175624 ·Status: COMPLETED ·Phase: NA
-
Bactericidal Permeability Protein Inhibitor and Interleukin-1beta Levels After Non-surgical Periodontal Treatment
NCT06354504 ·Status: COMPLETED ·Phase: NA
-
Assessment of Salivary GM-CSF, MIP, and IL-1β Levels in Subjects With Varying Periodontal Conditions
NCT06961409 ·Status: RECRUITING
-
Interleukin 20 and Periodontal Tisuue Destruction
NCT06091800 ·Status: COMPLETED
-
GCF Galectin-3 and Interleukin-1beta Levels in Periodontitis.
NCT05449093 ·Status: COMPLETED
-
Relationships Between Tenascin C, Smoking and Periodontal Status
NCT06523205 ·Status: NOT_YET_RECRUITING
-
Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis
NCT02808988 ·Status: COMPLETED ·Phase: PHASE4
-
EVALUATION OF SALIVA AND SERUM HEME OXYGENASE, ARYLESTERASE AND NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 LEVELS IN PATIENTS WITH STAGE III PERIODONTITIS
NCT06986044 ·Status: COMPLETED
-
The Effect of Non-Surgical Periodontal Therapy on Rheumatoid Arthritis
NCT06245265 ·Status: COMPLETED ·Phase: NA
-
Impact of Smoking on Salivary Interleukin (IL)-39, IL-41, IL-1β, TNF-α Levels in Periodontal Disease
NCT06528522 ·Status: NOT_YET_RECRUITING
-
Gingival Crevicular Fluid Levels of Sclerostin, Osteoprotegerin (OPG) and RANKL in Health, Disease and After Treatment
NCT02390479 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of Non-Surgical Periodontal Treatment on Biomarker Levels
NCT06178081 ·Status: COMPLETED ·Phase: NA
-
Assessment of Salivary Biomarker Levels in Individuals With Various Periodontal Diseases
NCT07025291 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Salivary and Serum Levels of TNF-α, IL-17A, and YKL-40 in Individuals With Psoriasis
NCT06984237 ·Status: ACTIVE_NOT_RECRUITING
-
GCF PLAP-1, Sclerostin and TNF-α Levels in Periodontitis
NCT05656989 ·Status: COMPLETED